260 related articles for article (PubMed ID: 29673080)
21. Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.
Joven BE; Almodovar R; Carmona L; Carreira PE
Semin Arthritis Rheum; 2010 Feb; 39(4):285-93. PubMed ID: 19782387
[TBL] [Abstract][Full Text] [Related]
22. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
[TBL] [Abstract][Full Text] [Related]
23. Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database.
Carreira PE; Carmona L; Joven BE; Loza E; Andréu JL; Riemekasten G; Vettori S; Balbir-Gurman A; Airò P; Walker U; Damjanov N; Matucci-Cerinic M; Ananieva LP; Rednic S; Czirják L; Distler O; Farge D; Hesselstrand R; Corrado A; Caramaschi P; Tikly M; Allanore Y
Scand J Rheumatol; 2019 Jan; 48(1):42-51. PubMed ID: 30039730
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for malignancy in systemic sclerosis patients.
Kaşifoğlu T; Yaşar Bilge Ş; Yıldız F; Özen G; Pehlivan Y; Yılmaz N; Tarhan F; Yılmaz S; Küçük A; Emmungil H; Koca SS; Çınar M; Direskeneli H; Erken E; Can G; Özmen M; Gönüllü E; Kisacik B; Aksu K; Karadağ O; Kasifoglu N; Arslantas D; Sahin F; Keser G; Yavuz S; Birlik M; Onat AM
Clin Rheumatol; 2016 Jun; 35(6):1529-33. PubMed ID: 27118199
[TBL] [Abstract][Full Text] [Related]
25. Malnutrition is an independent risk factor for mortality in Mexican patients with systemic sclerosis: a cohort study.
Cruz-Domínguez MP; García-Collinot G; Saavedra MA; Montes-Cortes DH; Morales-Aguilar R; Carranza-Muleiro RA; Vera-Lastra OL; Jara LJ
Rheumatol Int; 2017 Jul; 37(7):1101-1109. PubMed ID: 28555363
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan.
Kuo CF; See LC; Yu KH; Chou IJ; Tseng WY; Chang HC; Shen YM; Luo SF
Scand J Rheumatol; 2011; 40(5):373-8. PubMed ID: 21388247
[TBL] [Abstract][Full Text] [Related]
27. Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening.
Lazzaroni MG; Cavazzana I; Colombo E; Dobrota R; Hernandez J; Hesselstrand R; Varju C; Nagy G; Smith V; Caramaschi P; Riccieri V; Hachulla E; Balbir-Gurman A; Chatelus E; Romanowska-Próchnicka K; Araújo AC; Distler O; Allanore Y; Airò P;
J Rheumatol; 2017 May; 44(5):639-647. PubMed ID: 28089973
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers.
Barnes J; Mayes MD
Curr Opin Rheumatol; 2012 Mar; 24(2):165-70. PubMed ID: 22269658
[TBL] [Abstract][Full Text] [Related]
29. Venous Thromboembolism in Systemic Sclerosis: Prevalence, Risk Factors, and Effect on Survival.
Johnson SR; Hakami N; Ahmad Z; Wijeysundera DN
J Rheumatol; 2018 Jul; 45(7):942-946. PubMed ID: 29657152
[TBL] [Abstract][Full Text] [Related]
30. Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature.
Pokeerbux MR; Giovannelli J; Dauchet L; Mouthon L; Agard C; Lega JC; Allanore Y; Jego P; Bienvenu B; Berthier S; Mekinian A; Hachulla E; Launay D
Arthritis Res Ther; 2019 Apr; 21(1):86. PubMed ID: 30944015
[TBL] [Abstract][Full Text] [Related]
31. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease.
Scalapino K; Arkachaisri T; Lucas M; Fertig N; Helfrich DJ; Londino AV; Steen VD; Medsger TA
J Rheumatol; 2006 May; 33(5):1004-13. PubMed ID: 16583463
[TBL] [Abstract][Full Text] [Related]
32. Predictors of survival and causes of death in Japanese patients with systemic sclerosis.
Hashimoto A; Tejima S; Tono T; Suzuki M; Tanaka S; Matsui T; Tohma S; Endo H; Hirohata S
J Rheumatol; 2011 Sep; 38(9):1931-9. PubMed ID: 21765111
[TBL] [Abstract][Full Text] [Related]
33. High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis.
Tomiyama F; Watanabe R; Ishii T; Kamogawa Y; Fujita Y; Shirota Y; Sugimura K; Fujii H; Harigae H
Tohoku J Exp Med; 2016 Aug; 239(4):297-305. PubMed ID: 27487743
[TBL] [Abstract][Full Text] [Related]
34. 2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group.
Alhajeri H; Hudson M; Fritzler M; Pope J; Tatibouet S; Markland J; Robinson D; Jones N; Khalidi N; Docherty P; Kaminska E; Masetto A; Sutton E; Mathieu JP; Ligier S; Grodzicky T; LeClercq S; Thorne C; Gyger G; Smith D; Fortin PR; Larché M; Baron M
Arthritis Care Res (Hoboken); 2015 Apr; 67(4):582-7. PubMed ID: 25233870
[TBL] [Abstract][Full Text] [Related]
35. Early Mortality in a Multinational Systemic Sclerosis Inception Cohort.
Hao Y; Hudson M; Baron M; Carreira P; Stevens W; Rabusa C; Tatibouet S; Carmona L; Joven BE; Huq M; Proudman S; Nikpour M; ;
Arthritis Rheumatol; 2017 May; 69(5):1067-1077. PubMed ID: 28029745
[TBL] [Abstract][Full Text] [Related]
36. A systematic review of the epidemiology, disease characteristics and management of systemic sclerosis in Australian adults.
Morrisroe K; Stevens W; Proudman S; Nikpour M
Int J Rheum Dis; 2017 Nov; 20(11):1728-1750. PubMed ID: 29076640
[TBL] [Abstract][Full Text] [Related]
37. The effect of male sex on survival in systemic sclerosis.
Hussein H; Lee P; Chau C; Johnson SR
J Rheumatol; 2014 Nov; 41(11):2193-200. PubMed ID: 25274896
[TBL] [Abstract][Full Text] [Related]
38. [Survival and death causes in 251 systemic sclerosis patients from a single Italian center].
Vettori S; Cuomo G; Abignano G; Iudici M; Valentini G
Reumatismo; 2010; 62(3):202-9. PubMed ID: 21052567
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosis.
Solanki KK; Hor C; Chang WSJ; Frampton C; White DHN
Int J Rheum Dis; 2017 Jun; 20(6):767-773. PubMed ID: 28261995
[TBL] [Abstract][Full Text] [Related]
40. Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis.
Ruangjutipopan S; Kasitanon N; Louthrenoo W; Sukitawut W; Wichainun R
J Med Assoc Thai; 2002 Nov; 85(11):1204-9. PubMed ID: 12546318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
